Medicare Enrolled
Dr. Carlos Taboada, MD
Medical Oncology · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Taboada from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Taboada? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Taboada
Dr. Carlos Taboada is a medical oncology in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Taboada performed 46,737 Medicare services across 2,827 unique beneficiaries.
Between the years covered by Open Payments, Dr. Taboada received a total of $5,998 from 57 pharmaceutical and/or device companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Taboada is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 22% volume in TX$ $5,998 industry payments
Medicare Practice Summary
Medicare Utilization ↗46,737
Medicare services
Top 22% in TX for medical oncology
2,827
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,460 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 14,400 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 8,805 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 6,415 | $0 | $3 |
| Pembrolizumab injection (Keytruda) | 4,200 | $43 | $136 |
| Paclitaxel chemotherapy injection | 1,864 | $0 | $8 |
| Immune globulin infusion (Octagam) | 1,710 | $34 | $235 |
| Denosumab injection (Prolia/Xgeva) | 1,260 | $18 | $66 |
| Dexamethasone injection (steroid) | 1,006 | $0 | $1 |
| Blood draw (venipuncture) | 903 | $8 | $20 |
| Complete blood count (CBC) with differential | 824 | $8 | $36 |
| Comprehensive metabolic blood panel | 717 | $10 | $64 |
| Injection, bortezomib, 0.1 mg | 665 | $4 | $116 |
| Office visit, established patient (30-39 min) | 575 | $90 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 560 | $0 | $24 |
| Injection of additional new drug or substance into vein | 250 | $12 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 190 | $1 | $114 |
| Administration of chemotherapy into vein, 1 hour or less | 165 | $95 | $707 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 131 | $20 | $128 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 117 | $48 | $313 |
| Ferritin level test (iron stores) | 103 | $13 | $60 |
| Iron level test | 101 | $6 | $27 |
| Iron binding capacity test | 101 | $9 | $35 |
| Microscopic examination for white blood cells with manual cell count | 96 | $4 | $22 |
| Complete blood count (CBC), automated | 96 | $6 | $34 |
| Drug injection, under skin or into muscle | 94 | $11 | $96 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 80 | $88 | $657 |
| Injection, carboplatin, 50 mg | 78 | $2 | $300 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 75 | $1,101 | $4,802 |
| Office visit, established patient (20-29 min) | 73 | $56 | $250 |
| Hospital follow-up visit, moderate complexity | 73 | $61 | $247 |
| Lactate dehydrogenase (enzyme) level | 71 | $6 | $31 |
| Infusion, normal saline solution , 1000 cc | 64 | $2 | $19 |
| Ct scan of chest with contrast | 63 | $47 | $821 |
| Office visit, established patient, complex (40-54 min) | 61 | $135 | $496 |
| CT scan of abdomen and pelvis with contrast | 58 | $170 | $1,067 |
| Injection, diphenhydramine hcl, up to 50 mg | 58 | $1 | $7 |
| Administration of chemotherapy into vein, each additional hour | 55 | $21 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 51 | $49 | $344 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 50 | $22 | $157 |
| Unclassified drugs | 50 | $1 | $8 |
| Reticulated (young) platelet measurement | 49 | $35 | $143 |
| New patient office visit (45-59 min) | 48 | $124 | $565 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 44 | $55 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 40 | $15 | $100 |
| Carcinoembryonic antigen (cea) protein level | 39 | $19 | $99 |
| CT scan of chest, without contrast | 29 | $41 | $686 |
| Infusion into a vein for hydration, each additional hour | 28 | $10 | $75 |
| Infusion into a vein for hydration, 31-60 minutes | 27 | $24 | $256 |
| Hospital follow-up visit, high complexity | 23 | $91 | $357 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 22 | $15 | $94 |
| Manual urinalysis test with examination using microscope, non-automated | 20 | $4 | $26 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 18 | $333 | $1,722 |
| Ct scan of abdomen and pelvis without contrast | 16 | $62 | $560 |
| Drawing of blood for a medical problem | 14 | $72 | $264 |
| Red blood count automated, with additional calculations | 12 | $5 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
86.4% medium
9.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,998
Total received (2018-2024)
Avg $857/year across 7 years
Top 44% in TX for medical oncology
57
Companies
146
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,875 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$123 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$896
2023$1,164
2022$1,513
2021$685
2020$316
2019$899
2018$526
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$626
Ethicon US, LLC
$603
Novartis Pharmaceuticals Corporation
$360
Exelixis Inc.
$282
Pacira Pharmaceuticals Incorporated
$242
Gilead Sciences, Inc.
$200
Allergan Inc.
$154
Sirtex Medical Inc
$152
Janssen Biotech, Inc.
$151
Biom'Up France SAS
$149
TELA Bio, Inc.
$146
DAVOL INC.
$136
Covidien LP
$134
Novo Nordisk Inc
$133
Pharmacyclics LLC, An AbbVie Company
$131
AstraZeneca Pharmaceuticals LP
$130
Axonics, Inc.
$127
Synergy Pharmaceuticals Inc
$125
Medtronic USA, Inc.
$125
Merck Sharp & Dohme LLC
$113
Integra LifeSciences Corporation
$111
Dova Pharmaceuticals
$108
Sanara MedTech Inc.
$108
Trevena, Inc.
$100
Fresenius Kabi USA, LLC
$100
RedHill Biopharma Inc.
$98
AbbVie, Inc.
$95
CTI BioPharma Corp.
$92
Daiichi Sankyo Inc.
$89
PharmaEssentia USA Corporation
$69
GlaxoSmithKline, LLC.
$67
E.R. Squibb & Sons, L.L.C.
$63
GENZYME CORPORATION
$62
Seagen Inc.
$47
Tempus AI, Inc
$47
Incyte Corporation
$46
ABBVIE INC.
$42
Puma Biotechnology, Inc.
$35
Ferring Pharmaceuticals Inc.
$35
PFIZER INC.
$28
Kite Pharma, Inc.
$28
Blueprint Medicines Corporation
$27
EISAI INC.
$26
AbbVie Inc.
$25
Acrotech Biopharma LLC
$24
Amgen Inc.
$23
SOBI, INC
$22
GE HealthCare
$21
Genentech USA, Inc.
$19
Agios Pharmaceuticals, Inc.
$19
Karyopharm Therapeutics Inc.
$19
ADC Therapeutics America, Inc.
$17
Apellis Pharmaceuticals, Inc.
$15
Ipsen Biopharmaceuticals, Inc
$15
EUSA Pharma (US) LLC
$14
EMD Serono, Inc.
$13
Siemens Medical Solutions USA, Inc.
$12
Top 3 companies account for 26.5% of total payments
Associated products mentioned in payments ›
AYVAKIT · Aemcolo · Axonics r-SNM System · BELEODAQ · BESREMI · BLENREP · CABLIVI · CLENPIQ · CODMAN CERTAS · Cabometyx · CellerateRx · DARZALEX · Doptelet · ECHELON ENDOPATH · ENHERTU · EPKINLY · Echelon Flex · Echelon; Endopath · Empaveli · Enhertu · Exparel · Fabhalta · HEMOBLAST BELLOWS · IBRANCE · IMBRUVICA · IMFINZI · IMMULITE Immunoassay Reagents/Test Kit/Clinical Utilization · INTERSTIM ICON · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Nplate · OJJAARA · OLINVYK · ONUREG · OPDIVO · OPDUALAG · Ovitex · Ozempic · PADCEV · PHASIX · PIQRAY · PLUVICTO · Pomalyst · RYBREVANT · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · STRATTICE · Skyrizi · Smoflipid · Sonicision · Sylvant · TABRECTA · TECVAYLI · Tecentriq · Trodelvy · Trulance · VENCLEXTA · Vonjo · XPOVIO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $13 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
75
Per 100K population
6.7
County median income
$117,588
Nearest hospital
MEDICAL CITY PLANO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Taboada is a mixed practice specialist, with above-average Medicare volume (top 22% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Taboada experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Taboada performed 14,400 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Taboada receive payments from pharmaceutical companies?
Yes. Dr. Taboada received a total of $5,998 from 57 companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Taboada's costs compare to other medical oncologys in Plano?
Dr. Taboada's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Taboada) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Plano
Browse medical oncologys in Plano ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in TX
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in TX
Which TX medical oncologys receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Ethicon US, LLC Payments to Doctors
See all physicians who received payments from Ethicon US, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology